Valneva【VLA】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

2.728

買値

2.70

売値

2.74

出来高

4,717,102

2.534 日の範囲 2.82

1.726 52 週間の範囲 4.298

時価総額

377.015M

前日終値

2.46

始値

2.536

時刻

221

2.728

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

837,008

発行済株式数

138,202,132

配当利回り

PER

-3.72

1 株当たり利益 (EPS)

-0.73

歳入

175.73M

純利益

-101.43M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.valneva.com

本社

Saint-herblain, Loire-atlantique, Fra

設立

Valneva SE is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker VLA. The last closing price for Valneva was 2.46 €. Over the last year, Valneva shares have traded in a share price range of 1.726 € to 4.298 €.

Valneva currently has 138,202,132 shares in issue. The market capitalisation of Valneva is 339.98 € million. Valneva has a price to earnings ratio (PE ratio) of -3.72.

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA...

Valneva annonce un nouveau contrat d’une valeur minimale de $32.8 millions avec le gouvernement américain pour la fourniture de son vaccin IXIARO®

Valneva annonce un nouveau contrat d’une valeur minimale de $32.8 millions avec le gouvernement américain pour la fourniture de son vaccin IXIARO® Saint Herblain (France), le 30 janvier 2025 –...

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million

Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United...

Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision

Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision Saint-Herblain (France), January 22, 2025 – Valneva SE (Nasdaq: VALN; Euronext...

Valneva annonce des résultats de Phase 2 positifs chez les enfants pour son vaccin contre le chikungunya ainsi que la dose sélectionnée pour la Phase 3

Valneva annonce des résultats de Phase 2 positifs chez les enfants pour son vaccin contre le chikungunya ainsi que la dose sélectionnée pour la Phase 3 Saint-Herblain (France), le 22 janvier 2025...

Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision

Saint-Herblain (France), January 22, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive results for its Phase 2 clinical trial evaluating the safety and immunogenicity...

Valneva annonce une réponse immunitaire robuste et durable chez les adolescents un an après une seule vaccination avec son vaccin contre le chikungunya

Valneva annonce une réponse immunitaire robuste et durable chez les adolescents un an après une seule vaccination avec son vaccin contre le chikungunya Saint-Herblain (France), le 20 janvier 2025...

Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine

Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine Saint-Herblain (France), January 20, 2025 – Valneva SE (Nasdaq: VALN;...

Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine

Saint-Herblain (France), January 20, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its...

Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference

Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference Saint Herblain (France), le 6 janvier 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.43	18.7119234117	2.298	2.82	2.202	889593	2.35404233	DE
4	0.368	15.593220339	2.36	2.82	2.05	755975	2.25027023	DE
12	0.21	8.33995234313	2.518	2.82	1.726	837008	2.07991887	DE
26	-0.588	-17.7322074789	3.316	3.93	1.726	676046	2.48229205	DE
52	-1.022	-27.2533333333	3.75	4.298	1.726	608404	2.96331685	DE
156	-12.342	-81.897810219	15.07	18.92	1.726	527827	6.65376	DE
260	-0.382	-12.2829581994	3.11	29.7	1.726	697690	10.63086962	DE

VLA - Frequently Asked Questions (FAQ)

What is the current Valneva share price?

The current share price of Valneva is 2.728 €

How many Valneva shares are in issue?

Valneva has 138,202,132 shares in issue

What is the market cap of Valneva?

The market capitalisation of Valneva is EUR 339.98M

What is the 1 year trading range for Valneva share price?

Valneva has traded in the range of 1.726 € to 4.298 € during the past year

What is the PE ratio of Valneva?

The price to earnings ratio of Valneva is -3.72

What is the cash to sales ratio of Valneva?

The cash to sales ratio of Valneva is 2.15

What is the reporting currency for Valneva?

Valneva reports financial results in EUR

What is the latest annual turnover for Valneva?

The latest annual turnover of Valneva is EUR 175.73M

What is the latest annual profit for Valneva?

The latest annual profit of Valneva is EUR -101.43M

What is the registered address of Valneva?

The registered address for Valneva is 6 RUE ALAIN BOMBARD, CAMPUS BIO-OUEST, SAINT-HERBLAIN, LOIRE-ATLANTIQUE, 44800

What is the Valneva website address?

The website address for Valneva is www.valneva.com

Which industry sector does Valneva operate in?

Valneva operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ALCYBCybergun	0.0002 € (100.00%)	63.2M
TUVDSBio UV Group DS	0.015 € (70.45%)	490.92k
CANDCandela Invest	1.70 € (70.00%)	42
BIODSBiosynex DS	0.07 € (39.44%)	55.52k
ALGTRGroupe Tera SA	4.10 € (25.77%)	17.71k
MLIMLImalliance	0.282 € (-27.32%)	1.5k
ALCARCarmat	0.822 € (-22.60%)	3.04M
MLOCTOctopus Biosafety	0.14 € (-21.35%)	18.55k
ALEXPOne Experience	0.386 € (-21.22%)	933
SNGSonagi	0.80 € (-20.00%)	800
ATOAtos SE	0.0023 € (4.55%)	608.11M
ALVERVergnet	0.0011 € (0.00%)	92.88M
ALCYBCybergun	0.0002 € (100.00%)	63.2M
BCPBanco Comercial Portugues SA	0.5054 € (0.04%)	32.95M
ALHPIHopium SA	0.0028 € (-6.67%)	15.99M